Pharma-Bio Serv (PBSV) Non Operating Interest Expenses (2010 - 2013)

Pharma-Bio Serv (PBSV) has reported Non Operating Interest Expenses for 4 consecutive years, with $1903.0 the latest figure, recorded in Q2 2013.

• For the quarter ending Q2 2013, Non Operating Interest Expenses fell 8.55% year-over-year to $1903.0; the trailing twelve-month figure through Apr 2013 stood at $7100.0 (down 6.48% YoY), and the FY2013 full-year result was $7213.0, down 2.86% from the prior year.
• Non Operating Interest Expenses retreated to $1903.0 in Q2 2013 per PBSV's latest filing, from $2100.0 in the prior quarter.
• Across five years, Non Operating Interest Expenses topped out at $2575.0 in Q3 2011 and bottomed at $689.0 in Q4 2011.
• Historically, Non Operating Interest Expenses has averaged $1745.1 across 4 years, with a median of $1909.0 in 2012.
• The widest YoY moves for Non Operating Interest Expenses: up 72.01% in 2011, down 51.17% in 2011.
• Over 4 years, Non Operating Interest Expenses stood at $1411.0 in 2010, then slumped by 51.17% to $689.0 in 2011, then jumped by 71.55% to $1182.0 in 2012, then soared by 61.0% to $1903.0 in 2013.
• According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $1903.0, $2100.0, and $1182.0 for Q2 2013, Q1 2013, and Q4 2012 respectively.